How Inflammation Triggers Gene Changes in Type 1 Diabetes

Type 1 diabetes develops when the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This autoimmune process is driven by inflammation—the body's overactive immune response. A key inflammatory molecule called interleukin-1 beta (IL-1β) plays a major role in this damage.

When beta cells are exposed to IL-1β, their gene expression—which genes are turned on or off—changes dramatically. These changes have long been suspected to contribute to the disease, but scientists didn't know exactly how inflammation rewires the cell's molecular machinery.

Researchers used three complementary techniques to understand how IL-1β reshapes beta cells. RNA sequencing measured which genes were activated. Single-cell RNA sequencing revealed which genes turned on in individual cells. Chromatin immunoprecipitation (ChIP-Seq) pinpointed exactly where on the genome key proteins attach to control genes.

The results were consistent: exposure to IL-1β triggered a set of early-response genes that matched patterns found in pancreatic tissue from people with Type 1 diabetes. This overlap strengthens the case that understanding how IL-1β works in the lab could explain what happens in the disease.

The study identified a protein called NF-κB p65 as a central controller of the inflammatory response. When IL-1β signals arrive, p65 acts like a master switch, directing the cell's machinery to specific regions of the genome and activating genes relevant to autoimmune disease.

Computer simulations suggested that certain mutations affecting p65's function wouldn't prevent it from binding to DNA—only from activating genes once bound. This distinction matters because it hints at how the inflammatory process might be specifically targeted without completely shutting down p65.

A notable strength of this research is that the inflammatory genes activated by IL-1β were conserved across mice, rats, and humans. This suggests the findings aren't unique to laboratory models but reflect a fundamental biological mechanism relevant to human Type 1 diabetes.

By identifying these shared inflammatory genes and the proteins that control them, researchers have created a more detailed map of how autoimmunity damages beta cells—a necessary step toward developing new strategies to prevent or reverse that damage.

Source: American journal of physiology. Endocrinology and metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.